Track topics on Twitter Track topics that are important to you
Acquired in Ignyta buyout
Along with other recently acquired cancer companies like Ignyta and Array, Loxo proved out a drug development model that Bilenker likens to baseball's "moneyball" thesis.
Former Ignyta executive Zachary Hornby wasn't wowed by immuno-oncology pitches when looking for his next cancer drug development company, but...
Japan has become the first country to approve Roche’s personalised cancer drug Rozlytrek (entrectinib). Roche added entrectinib to its pipeline through its $1.7 billion buyout of Ignyta at the end ...
Ignyta, Inc., located in San Diego, California, is a personalized medicine company developing revolutionary new products and services to customize diagnosis and treatment of patie...
At Ignyta, we fight cancer â a formidable opponent that manifests as thousands of different molecularly defined diseases and takes away millions of lives globally, every year...
We have published hundreds of Ignyta Inc. news stories on BioPortfolio along with dozens of Ignyta Inc. Clinical Trials and PubMed Articles about Ignyta Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ignyta Inc. Companies in our database. You can also find out about relevant Ignyta Inc. Drugs and Medications on this site too.
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...